148 related articles for article (PubMed ID: 276611)
1. Novel arabinofuranosyl derivatives of cytosine resistant to enzymatic deamination and possessing potent antitumor activity.
Bobek M; Cheng YC; Bloch A
J Med Chem; 1978 Jul; 21(7):597-8. PubMed ID: 276611
[No Abstract] [Full Text] [Related]
2. Pyrimidine nucleosides. 6. Syntheses and anticancer activities of N4-substituted 2,2'-anhydronucleosides.
Kanai T; Ichino M
J Med Chem; 1974 Oct; 17(10):1076-8. PubMed ID: 4529302
[No Abstract] [Full Text] [Related]
3. Studies on biologically active nucleosides and nucleotides. 5. Synthesis and antitumor activity of some 2,2'-anhydro-1-(3',5'-di-O-acyl-beta-D-arabinofuranosyl)cytosine salts and 2,2'-anhydro-1-(3'-O-acyl-beta-D-arabinofuranoxyl)cytosine 5'-phosphates.
Kondo K; Nagura T; Arai Y; Inoue I
J Med Chem; 1979 Jun; 22(6):639-46. PubMed ID: 458820
[TBL] [Abstract][Full Text] [Related]
4. Antitumor characteristics of the conjugate of N4-(4-carboxybutyryl)-ara-C with ethylenediamine-introduced dextran and its resistance to cytidine deaminase.
Onishi H; Pithayanukul P; Nagai T
Drug Des Deliv; 1990 Oct; 6(4):273-80. PubMed ID: 1707277
[TBL] [Abstract][Full Text] [Related]
5. 2'-O-nitro-1-beta-D-arabinofuranosylcytosine. A new derivative of 1-beta-D-arabinofuranosylcytosine that resists enzymatic deamination and has antileukemic activity.
Chwang TL; Fridland A; Avery TL
J Med Chem; 1983 Feb; 26(2):280-3. PubMed ID: 6827546
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activities of newly synthesized N4-acyl-1-beta-D-arabinofuranosylcytosine.
Aoshima M; Tsukagoshi S; Sakurai Y; Oh-ishi J; Ishida T
Cancer Res; 1976 Aug; 36(8):2726-32. PubMed ID: 1277182
[TBL] [Abstract][Full Text] [Related]
7. Nucleoside conjugates. 11. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine and cytidine conjugates of thioether lipids.
Hong CI; Kirisits AJ; Nechaev A; Buchheit DJ; West CR
J Med Chem; 1990 May; 33(5):1380-6. PubMed ID: 2329558
[TBL] [Abstract][Full Text] [Related]
8. Effect and mode of action of N4-behenoyl-beta-D-arabinofuranosylcytosine.
Kataoka T; Sakurai Y
Recent Results Cancer Res; 1980; 70():147-51. PubMed ID: 7355245
[TBL] [Abstract][Full Text] [Related]
9. Antileukemic activity of 1-beta-D-arabinofuranosyl-2-amino-1,4(2H)-4-iminopyrimidine, a new depot form of 1-beta-D-arabinofuranosylcytosine.
Khwaja TA; Kigwana LJ; Mian AM
Cancer Res; 1979 Aug; 39(8):3129-33. PubMed ID: 455296
[No Abstract] [Full Text] [Related]
10. Antitumor activity of a novel orally effective nucleoside, 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl)cytosine.
Miura S; Yoshimura Y; Endo M; Machida H; Matsuda A; Tanaka M; Sasaki T
Cancer Lett; 1998 Jul; 129(1):103-10. PubMed ID: 9714341
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biologic examination of some derivatives of 2,2'-anhydro-1-(beta-d-arabinofuranosyl)cytosine hydrochloride (NSC-145668).
Moffatt JG; Hamamura EK; Russell AF; Prystasz M; Verheyden JP; Yamaguchi K; Uchida N; Sato K; Nishiyama S; Shiratori O; Katagiri K
Cancer Chemother Rep; 1974; 58(4):451-69. PubMed ID: 4854565
[No Abstract] [Full Text] [Related]
12. Treatment of L1210 murine leukemia with liposome-incorporated N4-hexadecyl-1-beta-D-arabinofuranosyl cytosine.
Schwendener RA; Schott H
Int J Cancer; 1992 May; 51(3):466-9. PubMed ID: 1592536
[TBL] [Abstract][Full Text] [Related]
13. Deamination rates of 1-beta-D-arabinofuranosylcytosine, deoxycytidine and 5-methyl-2'-deoxycytidine in seven hematopoietic cell lines.
Jekunen A
Med Biol; 1987; 65(4):203-8. PubMed ID: 3437781
[TBL] [Abstract][Full Text] [Related]
14. Nucleosides and nucleotides. 122. 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosylcytosine and its derivatives. A new class of nucleoside with a broad antitumor spectrum.
Azuma A; Nakajima Y; Nishizono N; Minakawa N; Suzuki M; Hanaoka K; Kobayashi T; Tanaka M; Sasaki T; Matsuda A
J Med Chem; 1993 Dec; 36(26):4183-9. PubMed ID: 8277499
[TBL] [Abstract][Full Text] [Related]
15. Potent inhibitors for the deamination of cytosine arabinoside and 5-aza-2'-deoxycytidine by human cytidine deaminase.
Laliberté J; Marquez VE; Momparler RL
Cancer Chemother Pharmacol; 1992; 30(1):7-11. PubMed ID: 1375134
[TBL] [Abstract][Full Text] [Related]
16. 1-beta-D-arabinofuranosylcytosine conjugates of corticosteroids as potential antitumor agents.
Hong CI; Nechaev A; Kirisits AJ; Buchheit DJ; West CR
Eur J Cancer Clin Oncol; 1983 Aug; 19(8):1105-12. PubMed ID: 6684555
[TBL] [Abstract][Full Text] [Related]
17. Nucleic acids. 16. Orally active derivatives of ara-cytidine.
Wechter WJ; Gish DT; Greig ME; Gray GD; Moxley TE; Kuentzel SL; Gray LG; Gibbons AJ; Griffin RL; Neil GL
J Med Chem; 1976 Aug; 19(8):1013-7. PubMed ID: 966247
[TBL] [Abstract][Full Text] [Related]
18. [Experimental study on the correlation between the antitumor activity and pharmacokinetics of cytosine arabinoside (Ara-C) and N4-behenoyl-1-beta-D-arabinofuranosylcytosine (BH-AC)].
Takenaka T; Kimura K
Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2322-8. PubMed ID: 3831176
[No Abstract] [Full Text] [Related]
19. Nucleic acids. 11. Synthesis of 5'-esters of 1-beta-D-arabinofuranosylcytosine possessing antileukemic and immunosuppressive activity.
Gish DT; Kelly RC; Camiener GW; Wechter WJ
J Med Chem; 1971 Dec; 14(12):1159-62. PubMed ID: 5116227
[No Abstract] [Full Text] [Related]
20. Reactions of 2-acyloxyisobutyryl halides with nucleosides. 6. Synthesis and biological evaluation of some 3'-acyl derivatives of 2,2'-anhydro-1-(beta-D-arabinofuranosyl)cytosine hydrochloride.
Hamamura EK; Prystasz M; Verheyden JP; Moffatt JG
J Med Chem; 1976 May; 19(5):654-62. PubMed ID: 178871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
